Incubator Technologies

 

Brokered Technologies

  • Phase One Medical's Optional Vena Cava Filter Platform (www.phaseonemedical.com)
    - Removable, permanent or temporary IVC Filters
    - Provides option for permanent placement or unlimited removal times
    - Animal feasibility complete
    - Bench top and finite element analysis studies complete
    - I.P. issued
    - Unique medical device anchoring platform technology
    - Immediately available for acquisition or license
     

  • Medical Miracle's POLAR Chronic Total Occlusion device
    - Produces frequencies of 16 to 100 HZ while generating a combination of reciprocal and
      lateral movements to confidently cross occluded vessels
    - Employs the use of conventional guidewires
    - Multiple published clinical successes
    - CE Mark approved
    - I.P. issued
    - Immediately available for acquisition or license
     

  • Texan ® LONGhorn and mini-Tex™ - Foreign Body Retrieval Devices
    - Exclusively Brokered for IDev Technologies
    - 510K clearance and CE Mark approval
    - US patent issued - # 6,517,550
    - Existing US and OUS customer base
    - "One size fits all" expandable loop
    - Guidewire compatible
    - Immediately available for acquisition or license
     

  • AKónya Eliminator ® and AKónya Eliminator ® Plus - Mechanical Thrombectomy Devices
    - Exclusively Brokered for IDev Technologies
    - 510K clearance and CE Mark approval
    - US patent issued - # 6,146,396
    - Existing US and OUS customer base
    - 6F Adjustable Thrombasket (2-10 mm)
    - Immediately available for acquisition or license
     

  • High-flow Valve  --  Conceived by Greg Nordgren, a biomedical engineering expert with 23 issued and six pending patents to his credit, the FloTec™ valve utilizes proprietary design elements which allow for high pressure injections and over-the-wire placement without compromising valve integrity. Ideal applications for the FloTec™ include PICC lines, hemodialysis catheters and other central venous catheters. It has been estimated that the FloTec™ valve could enhance the performance of an estimated five million vascular access catheters used globally on an annual basis.
     

  • Ultrasonic Needle Visualization Technology  --  Conceived by Richard Fulton, M.D., a leading interventional radiologist and co-founder of Artemis Medical, Inc. (a Johnson and Johnson company), the technology utilizes proprietary design elements which allow for the precise and accurate placement of needles during interventional procedures utilizing ultrasonic visualization. Dr. Fulton’s technology illuminates the entire length of a needle, not just the tip, and at very steep or suboptimal angles, and does so without expensive or cumbersome coatings.
     

  • Hemostatic Agent Delivery System  --  Interventional Radiologist, Mark Saker, M.D.'s device precisely and accurately delivers hemostatic agents which prevent bleeding complications by sealing tissue tracts following solid organ or lung biopsies. 
     

  • HB Technology Core-tissue Biopsy Instrument  --  Features include both fully and semi-automated firing mechanisms and variable penetration depths of 6 mm – 22 mm.  This single-handed device is exceptionally compact, lightweight and incorporates a powerful firing mechanism making it ideal for both ultrasound and CT guided biopsies.   Needle guage options of 20, 16, 18, and 14 make it ideal for a wide range of soft tissue biopsies including liver, kidney, pancreas, prostate, thyroid, lung and breast.  Additional information on this technology is available at: http://www.visi-tek.com/hb/
     

  • Ossacur, AG -- FDA-cleared biologic implant, OSSAPLAST®  --  OSSAPLAST® is an implantable, fully resorbable β-tricalciumphosphate (β-TCP) ceramic in granular form that is used in the filling and reconstruction of bone defects. OSSAPLAST® consists of phase-pure β-TCP which enables shape-adapted defect filling, osteo-conductivity, and is both highly biocompatible and porous (outside the critical grain size of 500 – 1,000 µm)Hatch Medical is actively seeking distributors for OSSAPLAST® in the United States through an exclusive agreement with Ossacur, AG (http://www.ossacur.com).

     

If you would like additional information on these and other devices Hatch Medical has under development, click here and complete the registration form.

 

 


 

Hatch Medical, L.L.C.
8750 Islesworth Court
Duluth, GA 30097
Phone: 770-476-9940
Facsimile:  770-476-7740
info@hatchmedical.com

 

© 2001 - 2008 Hatch Medical, L.L.C. - All rights reserved